Allogene Therapeutics, Inc.

Biotechnology company · South San Francisco, California, United States · Nasdaq: ALLO

Allogene Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker ALLO. It has reported private securities offerings to the US SEC, most recently $412 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Allogene Therapeutics at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2017
Stock listingNasdaq: ALLO
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1737287

What does Allogene Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $411.8 million sold (2018).

Frequently asked questions about Allogene Therapeutics

Where is Allogene Therapeutics headquartered?

Allogene Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does Allogene Therapeutics do?

Allogene Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Allogene Therapeutics a public company?

Yes. Allogene Therapeutics, Inc. trades on Nasdaq under the ticker ALLO.

When was Allogene Therapeutics founded?

The earliest incorporation on record for Allogene Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Allogene Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX